A clinical study of efficacy of Haritaki for metabolic transformation of byproduct generated due to improper or incomplete digestion

Clinical study of efficacy of Haritaki (Terminalia chebula) for ama pachana.

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/05/042937

Enrollment

Registered

2022-05-31

Start date

Unknown

Completion date

Unknown

Last updated

2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K928- Other specified diseases of the digestive system

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1)Subjects having symptoms of ama as mentioned in Ashtang Hridaya i.e. srtorodha, balabhransha, gaurav, anilmoodhata, alasya, apakti, nishthiva, malasanga, aruchi, klama.

Exclusion criteria

Exclusion criteria: 1)Subjects with known case of chronic systemic diseases (like diabetes, hypertension etc.) 2) Subjects with Secondary emaciation (known case of prolonged infection) 3) Subjects with pregnancy or lactation 4) Subjects with immunocompromised diseases (such as AIDS, cancer etc.)

Design outcomes

Primary

Measure	Time frame
Haritaki is effective when given with hot water at madhyabhakta Kala in 3gm quantity twice a day.Timepoint: After 15 days follow up	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr Amruta sambhaji Atkare

Ashtang Ayurved Mahavidyalaya, Pune

drvijaybhandare@gmail.com9422080246

Outcome results